an increasing trendp < 0.001
Moreover, an increasing trend in rates of isolates non-susceptible to ciprofloxacin was also observed (p < 0.001) starting at 25.6% in 2010 to reach 32.2% in 2017.
Moreover, an increasing trend in rates of isolates non-susceptible to ciprofloxacin was also observed (p < 0.001) starting at 25.6% in 2010 to reach 32.2% in 2017.
High proportions of isolates with ceftazidime non-susceptibility were observed; however, a decreasing trend in both wards (from 61.8% to 58.5%) and ICUs (from 92.6% to 88.6%) (p = 0.027 and p = 0.001, respectively) was found from 2010 to 2017.